Navigation Links
Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
Date:4/1/2008

cial funding track for academic researchers, we will only increase the quality and quantity of applications we receive."

Under the 2008 TDI program, MJFF primarily seeks to support development of therapies that have the clear potential to provide a disease-modifying benefit (i.e., neuroprotection), something no currently available treatment can do, or to provide long-term and significant relief from PD symptoms above and beyond that offered by current therapies, including strategies to alleviate complications of current treatments such as dyskinesias (the disruptive movements that are a side effect of long-term levodopa use).The Foundation is also eager to support development of treatments that address 'non-motor' aspects of PD, such as cognitive dysfunction, depression, autonomic dysfunction and sleep disorders. In addition, MJFF is interested in novel and innovative therapeutic delivery platforms and technologies that can tackle key delivery barriers and safety concerns to greatly enhance ability of treatments to impact, target and treat PD.

The first two rounds of TDI were enthusiastically received by industry researchers and the scientific community at large. To date the Foundation has awarded nearly $8 million total under the initiative for 14 projects.

About The Michael J. Fox Foundation

The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. To date, the Foundation has funded $115 million in research directly or through partnerships.


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
2. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
3. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
4. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
5. Gates Foundation Seeks Proposals for Innovative Global Health Research
6. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
7. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
8. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
9. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
10. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
11. Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... SAN FRANCISCO , Aug. 31, 2015  On ... District of Oregon denied motions ... Inc. (NASDAQ: GALE ) and certain of its ... had facilitated a "pump and dump" scheme to artificially ... trading period while the stock price was inflated, sold ...
(Date:8/31/2015)... 31, 2015  Regulatory affairs professionals work at ... are often strict and legislation is ever-changing. The ... for professionals who have a deep understanding of ... product lifecycle and demonstrate its use across various ... California, Irvine Extension , in partnership with the ...
(Date:8/31/2015)... Aug. 31, 2015 Regen BioPharma, Inc. (OTCBB: ... a novel means of delivering its patented (US ... liver tumors utilizing a clinically approved formulation as ... hurdles with gene silencing therapeutics in which the ... the whole body.  By utilizing a local delivery ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, Inc.,(Nasdaq:AVII) ... target patient enrollment and released six-month,follow-up data from ... trial, currently being held in Germany, was designed ... Resten-MP(TM), when,used in conjunction with the placement of ...
... Fail to Demonstrate Meaningful Placebo Adjusted Weight,Loss; ... July 09, 2007 /PRNewswire-FirstCall/ -- Manhattan,Pharmaceuticals, Inc. ... 2a clinical trials of oral Oleoyl-estrone (OE). ... one,in common obesity and the other in ...
Cached Medicine Technology:AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4
(Date:9/1/2015)... , ... September 01, 2015 , ... September is Baby ... manufacturers use safety labels and stickers to keep little ones' safety top of mind ... Safety Month has a particular focus. According to the JPMA's Baby Safety Zone website, ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs for ... of new premium on-demand video Evidence Based Practice courses that ... 2014 must complete 50 CEUs before December 31, 2015, which must include at ...
(Date:8/31/2015)... ... August 31, 2015 , ... Sculpted Contours Luxury Medical ... Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. , ... as well as Kathy King. Her idea and vision to bring to Atlanta ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Southern Vacation ... – has teamed up with fellow South Walton property management company, 360 ... extreme poverty in remote parts of the world. The two companies will collect any ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... management, recently opened registration for the company’s second Introduction to Hyperbaric Medicine Course. ... October 15-18, 2015 aboard the Queen Mary Hotel in Long Beach, CA. The ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4
... (NSAIDs), such as aspirin and ibuprofen, may reduce serum ... and hence may alter the detection of prostate cancer ... conclusion of a new study in the October 15, ... journal of the American Cancer Society. , Chronic ...
... and ibuprofen appear to lower a man,s PSA level, the ... a man is at risk of prostate cancer. , But ... in the journal Cancer , caution that men shouldn,t ... just yet. , "We showed that men who regularly ...
... also been linked recently to patient deaths , , ... once-a-week formulation of the injectable diabetes drug Byetta ... twice-a-day formulation, researchers report. , "Besides obvious improved ... remarkable advantage of both improved efficacy on glucose ...
... Pathologists Discuss the Latest Developments in Molecular,Testing and ... The practice of,pathology is at a transformation point. ... change the way patients are treated. Digital,slides and ... The College of American Pathologists is taking a ...
... ROCKVILLE, Md., Sept. 5 The Health Resources,and ... grants to,increase and improve medical services at the ... Bush,s historic expansion of the,health center network, whose ... Americans than ever before," HRSA,Administrator Elizabeth M. Duke ...
... Researchers explain how theoretical ,anti-cloak, could bring objects out ... Just in case someone develops a cloak of invisibility, ... to uncloak the objects it hides. , According to ... materials underneath an invisibility cloak would allow invisible objects ...
Cached Medicine News:Health News:Anti-inflammatory drugs may mask prostate cancer marker 2Health News:Common painkillers lower levels of prostate cancer biomarker 2Health News:Once-Weekly Diabetes Drug Boosts Blood Sugar Control 2Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: